GPR156 regulates hair cell orientation through EMX2-dependent polarization :
Hair cell reversal mechanism:
Constitutive activity: Maintains baseline auditory function without ligand activation .
Pathological correlations: Knockout models show complete loss of lateral peak response (LPR) in utricles and saccules .
Commercial availability facilitates experimental studies:
| Vendor | Product Code | Format |
|---|---|---|
| Creative BioMart | GPR156-2654R | His-tagged mammalian cell |
| CUSABIO | CSB-CF817004RA | E.coli-expressed, no tag |
| Application | Clone | Reactivity |
|---|---|---|
| Western Blot | CSB-PA002763 | Human, cross-reactive |
| Immunofluorescence | CSB-PA844046LA01HU | Rat-specific |
Landmark studies demonstrated:
Non-canonical activation:
G protein coupling:
The structural blueprint enables targeted drug development for:
Congenital hearing loss (DFNB non-syndromic deafness loci)
Balance disorders linked to vestibular hair cell misorientation
Current research focuses on allosteric modulators that exploit the symmetrical active-state dimer interface .
GPR156 is a class C orphan G-protein-coupled receptor with an atypical structure that lacks the large Venus Flytrap (VFT) extracellular domain characteristic of other class C GPCRs. Unlike typical class C receptors, GPR156 possesses an extremely short N-terminal sequence (45 residues) that forms a small extracellular region with Extracellular Loop 2 (ECL2) . This structural difference contributes to its unique activation mechanism and high constitutive activity through Gi2/3 signaling pathways .
Native GPR156 is highly expressed in auditory hair cells (HCs) and plays a pivotal role in their functionality and orientation . It is also widely distributed throughout the rat central nervous system, though its physiological function in the CNS remains less characterized .
When producing recombinant rat GPR156, researchers should consider tissue-specific post-translational modifications. Expression systems should be selected based on research objectives:
| Expression System | Advantages | Limitations | Recommended Applications |
|---|---|---|---|
| E. coli | Cost-effective, high yield | Limited post-translational modifications | Structural studies, antibody production |
| Baculovirus | Better protein folding, some PTMs | More complex, moderate cost | Functional studies, protein-protein interactions |
| Mammalian cells | Native-like PTMs, proper folding | Higher cost, lower yield | Signaling studies, drug screening |
| In Vivo Biotinylation | Site-specific labeling | Technical complexity | Protein interaction studies, pull-down assays |
Each system produces proteins with different characteristics that may impact experimental outcomes .
Based on successful purification of human GPR156 for cryo-EM studies, the following optimized protocol can be adapted for rat GPR156:
Cell Lysis and Membrane Preparation:
Harvest cells and disrupt using nitrogen cavitation in buffer containing protease inhibitors
Collect membranes by ultracentrifugation (100,000×g for 1h)
Solubilization:
Solubilize membranes using 1% (w/v) lauryl maltose neopentyl glycol (LMNG) with 0.1% (w/v) cholesteryl hemisuccinate (CHS) for 2h at 4°C
Remove insoluble material by ultracentrifugation
Affinity Purification:
Apply solubilized material to Ni-NTA resin
Wash with buffer containing 0.01% (w/v) LMNG, 0.001% (w/v) CHS
Elute with imidazole gradient
Size Exclusion Chromatography:
Critical considerations include maintaining cold temperature throughout purification and minimizing time between steps to prevent protein degradation.
Two complementary approaches have been validated for measuring GPR156 activity:
BRET-based G Protein Dissociation Assay:
NanoBiT-based G Protein Recruitment Assay:
Both assays should include positive controls (known constitutively active GPCRs) and negative controls (mock-transfected cells) for proper interpretation.
Recent cryo-EM studies have provided unprecedented insights into GPR156's activation mechanism at resolutions of 3.09 Å (apo state) and 2.40 Å (G-protein-bound state) . Key findings include:
Novel Dimer Interface: GPR156 forms a homodimer with a unique TM5/6-TM5/6 interface that remains virtually unchanged between the apo and G-protein-bound states (RMSD of 0.494 Å) .
Active State Conformation: Both subunits in the apo state exhibit active-state conformations similar to G-protein-bound GABAB2, with key interactions including:
Absence of Ionic Lock: Unlike other class C GPCRs, GPR156 has S2576.35 instead of D6.35 or E6.35, preventing the formation of a stable ionic lock with K3.50, which contributes to its constitutive activity .
C-terminus Function: The C-terminus plays a dual role - promoting G protein binding in the G-bound subunit while simultaneously preventing additional G protein binding to the G-free subunit .
This structural information explains GPR156's high constitutive activity and provides a foundation for understanding its role in auditory function.
In vivo knockdown experiments have revealed the temporal importance of GPR156 in auditory function:
Developmental Effects: GPR156 knockdown during auditory development (P2-P3) leads to improper stereocilium deflection in hair cells, consistent with its role as a cell polarity determinant .
Maintenance Function: Knockdown in mature mice (P30 and P60) resulted in:
The experimental design involved AAV-mediated GPR156-shRNA delivery through the round window membrane, with contralateral ears serving as controls . This demonstrates that GPR156's constitutive activity is essential not only for establishing but also for maintaining auditory function throughout life.
Based on structural insights, the following key residues are prime targets for site-directed mutagenesis to elucidate structure-function relationships:
| Domain | Residue | Function | Mutation Strategy | Expected Effect |
|---|---|---|---|---|
| TM3 | K1413.50 | Active state stabilization | K141A | Reduced constitutive activity |
| TM3 | R1443.53 | Hydrogen bond network | R144A | Altered G protein coupling |
| TM2 | S842.35 | Active state stabilization | S84A | Decreased basal activity |
| TM3 | F1353.44 | Active conformation | F135A | Disrupted activation |
| TM5/TM6 interface | D2225.37, R2796.57 | Dimer formation | D222A, R279A | Impaired dimerization |
| C-terminus | C-terminal residues | G protein regulation | Truncation/deletion | Altered G protein binding pattern |
Mutations affecting the dimer interface (D2225.37 and R2796.57) would be particularly informative, as these residues form electrostatic interactions that tether the extracellular ends of both GPR156 monomers' TMDs .
Although GPR156 is considered an orphan receptor with high constitutive activity, systematic approaches to identify potential modulators include:
High-throughput Screening:
Establish stable cell lines expressing recombinant rat GPR156
Use BRET or NanoBiT assays to screen compound libraries
Focus on compounds that either enhance or inhibit constitutive activity
Structure-based Virtual Screening:
Utilize the cryo-EM structure to identify potential binding pockets
Perform in silico docking of compound libraries
Validate top hits using biochemical and cellular assays
Lipidomic Analysis:
Recent studies identified phosphatidylglycerol (PG) 36:2 (PG (18:1_18:1)) as an endogenous phospholipid bound to GPR156
Employ liquid chromatography-mass spectrometry (LC-MS/MS) to identify additional lipid modulators
Parameters: MS/MS assigned = TRUE; Total score ≥ 70; detected in all replicates; log2 fold change (logFC) ≥ 2
Successful identification of GPR156 modulators could provide valuable tools for studying its function and potential therapeutic applications for hearing loss.
Recombinant rat GPR156 serves as a valuable model for investigating hearing loss mechanisms through several experimental approaches:
In vitro Functional Reconstitution:
Reconstitute purified GPR156 into liposomes with Gi proteins
Assess basal and modulator-induced activity
Compare wild-type and disease-associated variants
Gene Therapy Models:
Precision Medicine Applications:
Screen patient-derived GPR156 variants for functional defects
Develop variant-specific therapeutic approaches based on mechanism of dysfunction
Recent studies demonstrating GPR156's essential role in both establishing and maintaining auditory function highlight its potential as a therapeutic target for congenital hearing loss .
When translating findings between species, researchers should consider:
Sequence Homology: Human and rat GPR156 share significant sequence homology but contain important differences that may affect:
G protein coupling specificity
Constitutive activity levels
Response to potential modulators
Expression Patterns:
Structural Conservation:
Key structural features like the TM5/6-TM5/6 dimer interface appear conserved
The C-terminus dual regulatory function may have species-specific aspects
Experimental Design:
Include both rat and human GPR156 in parallel experiments when possible
Validate findings in human cell models or tissues before clinical translation
Understanding these considerations will improve the translational relevance of findings from rat GPR156 studies to human auditory pathologies.
Based on recent research, the following computational approaches are recommended:
Molecular Dynamics Simulations:
System preparation: Embed GPR156 dimer in a 3:1 POPC:POPE and cholesterol bilayer
Parameters: Use CHARMM36m forcefield with TIP3P water model and 0.15 M Na+/Cl- ions
Equilibration: 5000 steps energy minimization, 250 ps NVT at 310 K, 1.5 ns NPT at 1 atm
Production: Multiple replicates with different initial velocities
Analysis: Cavity volume calculation with Epock (1.0.5) in VMD
Key Simulation Parameters:
These approaches can provide insights into conformational dynamics not directly observable in static cryo-EM structures.